Company: TAK
Filing Date: 2025-05-08
Form Type: 6-K
Source: 0001395064-25-000048
Chunk: 17

Company: TAKEDA PHARMACEUTICAL CO LTD
Filing Date: 2025-05-08
Form: 6-K
Chunk 17
---
usp alfa (TAK-573) and EXKIVITY (for non-small cell lung cancer).

#### Core Net Profit for the Year
Core Net Profit for the Year was JPY 775.8 billion ( JPY +18.9 billion and +2.5% AER, -3.4% CER) and Core Net Profit attributable to owners of the Company was JPY 775.6 billion (JPY +18.8 billion and +2.5% AER, -3.4% CER) and are calculated from Core Operating Profit as below:

| 2024                                                                      |     | For the fiscal year ended 
 March 31,                 |     | 2025 |         |     | Amount of Change |     |         |     | AER      
 % Change |     |       |     | % Change |     |       |   | CER |     |       | Billion JPY or percentage |
|:--------------------------------------------------------------------------|:----|:--------------------------|:----|:-----|--------:|:----|:-----------------|:----|--------:|:----|:---------|:----|------:|:----|:---------|:----|------:|:--|:----|:----|------:|:--------------------------|
| Core operating profit                                                     |     |                           |     |      | 1,054.9 |     |                  |     | 1,162.6 |     |          |     | 107.8 |     |          |     |  10.2 | % |     |     |   4.9 | %                         |
| Core finance income and (expenses), net                                   |     |                           |     |      |  -142.0 |     |                  |     |  -140.7 |     |          |     |   1.3 |     |          |     |  -0.9 | % |     |     |  -4.5 | %                         |
| Core share of profit of investments accounted for using the equity method |     |                           |     |      |     5.9 |     |                  |     |     1.1 |     |          |     |  -4.8 |     |          |     | -81.2 | % |     |     | -82.2 | %                         |
| Core profit before tax                                                    |     |                           |     |      |   918